Order Today

Many types of doctors are finding useful applications for the PulseWave® in their clinics. Both medical professionals and patients are very satisfied with PulseWave®.

Amniotic Fluid in Regenerative Medicine

Today, physicians are using regenerative cell therapies in the treatment of a wide variety of medical conditions and disorders. Presently, the use of amniotic fluid cells is commonly used in orthopedics as it may prevent many patients from having to resort to knee replacement or other surgical procedures and improve function of joints following injury or overuse. Practitioners today are also using regenerative cells in cases that involve pain management, cardiology, rheumatology and neurology to name a few.

Introduction to Anu RHEO+™

Anu RHEO+™ amniotic fluid matrix products are aseptically prepared, minimally manipulated human tissue allografts for homologous use.  Anu RHEO+™ is intended to supplement or replace damaged or inadequate connective tissue. Amniotic fluid is the clear to slightly yellowish fluid that surrounds a baby in the uterus.  It acts as cushion against hard blows to protect the baby and also helps to regulate the temperature as well. Amniotic fluid is a rich source of nutrients, cytokines, and growth factors that are required for fetal development and maturation.

The new RHEO+™ contains Wharton’s jelly; a mucous tissue within the umbilical cord that protects and insulates blood cells made from mucopolysaccharides such as hyaluronic acid and chondroitin sulfate. The MSC ‘s within Wharton’s jelly consist of functional myofibroblasts that can be isolated with minimal manipulation of the tissue, easily preserving their natural anti-inflammatory and pro-regenerative ability without complication or deterioration.

Anu RHEO+™ is a perfect match for synovial fluid in joints and exhibits anti-scarring and anti-adhesion in addition to anti-inflammatory properties.

Types of Allografts we offer

Anu RHEO+

Cord Blood

Exosomes

Advantages of Anu RHEO+™ Over Corticosteroid Injections

Syringe in the white background.

Corticosteroid injections have been used for a very long time. Their anti-inflammatory and pain relief properties have made its use a common practice within the medical community. Corticosteroid injections have been shown to be effective in decreasing the inflammation and pain of ligament injuries for up to 8 weeks. Simply, the body heals via inflammation, cortisone inhibits inflammation and healing by disrupting the three characteristic phases: inflammatory, proliferative and remodeling.

Amniotic fluid has very similar characteristics to the synovial fluid that is present in the joints.  The natural lubrication and anti-inflammatory properties help to create an ideal environment for your body to help the proliferation and remodeling of the damaged tissue via the native regenerative cells present in the body.

Rheo Plus™ comes in 1cc and 2cc

Why Would

Physicians Be Interested?

Anu RHEO+™ amniotic fluid matrix products with Wharton’s Jelly provide the extracellular matrix needed for the infiltration, attachment and proliferation of cells required for the repair of damaged tissue.  Amniotic fluid may reduce scarring, fibrosis, and adhesions in surgical and wound sites.  It may also promote tissue regeneration by providing an anti-microbial and anti-inflammatory environment at surgical and wound sites.

What Are

The Clinical Benefits?

Typically used for minimally invasive treatment of damaged or inadequate tissue. Amniotic fluid (AF) possesses anti-inflammatory, anti-microbial and regenerative properties that make it attractive for use in clinical applications.

Procurement Process

Syringe in the white background.

All birth tissue products are obtained from C-section deliveries from normal, full-term pregnancies.  Donors that consent to use of their birth tissues are carefully screened prior to the use of their tissues in manufacturing.

Comprehensive medical and social histories of the donors are obtained and tissues are procured, processed, and tested to minimize potential risks of disease transmission to recipients. Infectious disease testing is performed at a certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.

Each donor is tested for HBsAg  (Hepatitis  B  Surface  Antigen),  HBcAb  (hepatitis  B  core  Antibody), HCV (hepatitis C Antibody), HIV I/II-Ab (Antibody to Human Immunodeficiency Virus Types 1 and Syphilis detection test, HIV NAT (HIV Nucleic Acid Test), and HCV NAT (HCV Nucleic Acid  Test).

All products are tested post-sterilization to demonstrate the absence of bacterial and fungal pathogens and are non-pyrogenic. All testing results are reviewed by the Medical Director of Anu Life Sciences (15491 SW 12th Street, STE 408, Sunrise, FL 33326, 888-963-7881) prior to the release of the product.